Liposome Encapsulated SN38 (LE-SN38) in Patients With Advanced Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

August 31, 2007

Study Completion Date

November 30, 2010

Conditions
Neoplasms
Interventions
DRUG

Liposome-encapsulated SN38

Trial Locations (3)

33612

H. Lee Moffitt Cancer Center and Research Institute, Tampa

43210

The Ohio State University, Columbus

48201

Barbara Ann Karmanos Cancer Institute, Detroit

Sponsors
All Listed Sponsors
lead

INSYS Therapeutics Inc

INDUSTRY

NCT00046540 - Liposome Encapsulated SN38 (LE-SN38) in Patients With Advanced Cancer | Biotech Hunter | Biotech Hunter